A Hoffmann

588 total citations
38 papers, 443 citations indexed

About

A Hoffmann is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, A Hoffmann has authored 38 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 9 papers in Pediatrics, Perinatology and Child Health and 7 papers in Molecular Biology. Recurrent topics in A Hoffmann's work include Pharmacogenetics and Drug Metabolism (11 papers), Pharmaceutical studies and practices (8 papers) and Pharmacovigilance and Adverse Drug Reactions (3 papers). A Hoffmann is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Pharmaceutical studies and practices (8 papers) and Pharmacovigilance and Adverse Drug Reactions (3 papers). A Hoffmann collaborates with scholars based in Germany, France and Netherlands. A Hoffmann's co-authors include Joerg Hasford, Jerry Avorn, Sebastian Schneeweiß, Holger H. Sigusch, Katrin Farker, Marion Hippius, J. Schubert, Michael H. Lehmann, M. Öettel and Johannes Haerting and has published in prestigious journals such as European Journal of Clinical Pharmacology, The Journal of Heart and Lung Transplantation and International Journal of Molecular Medicine.

In The Last Decade

A Hoffmann

36 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Hoffmann Germany 9 133 126 118 106 76 38 443
Shadi Baniasadi Iran 12 138 1.0× 102 0.8× 74 0.6× 87 0.8× 48 0.6× 43 554
Bruno HCh Stricker Netherlands 13 177 1.3× 116 0.9× 165 1.4× 95 0.9× 142 1.9× 16 808
Katrin Farker Germany 10 134 1.0× 96 0.8× 41 0.3× 97 0.9× 75 1.0× 31 483
Katja S. Just Germany 13 103 0.8× 113 0.9× 149 1.3× 76 0.7× 161 2.1× 40 663
William N. Kelly United States 13 274 2.1× 140 1.1× 71 0.6× 168 1.6× 64 0.8× 47 671
Birgit Eiermann Sweden 13 244 1.8× 137 1.1× 189 1.6× 61 0.6× 91 1.2× 19 746
Syed Rizwanuddin Ahmad United States 6 59 0.4× 71 0.6× 228 1.9× 164 1.5× 43 0.6× 12 580
Just Ebbesen Norway 5 222 1.7× 105 0.8× 39 0.3× 90 0.8× 24 0.3× 9 426
Johanna Strandell Sweden 9 55 0.4× 99 0.8× 96 0.8× 249 2.3× 33 0.4× 15 489
Esther H. Zhou United States 16 66 0.5× 68 0.5× 110 0.9× 98 0.9× 37 0.5× 47 582

Countries citing papers authored by A Hoffmann

Since Specialization
Citations

This map shows the geographic impact of A Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Hoffmann more than expected).

Fields of papers citing papers by A Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Hoffmann. The network helps show where A Hoffmann may publish in the future.

Co-authorship network of co-authors of A Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of A Hoffmann. A scholar is included among the top collaborators of A Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Hoffmann. A Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farker, Katrin, et al.. (2006). Chronomodulated chemotherapy with oxaliplatin, 5-FU and sodium folinate in metastatic gastrointestinal cancer patients: analysis of non-hematological toxicity and patient characteristics in a. International Journal of Clinical Pharmacology and Therapeutics. 44(1). 31–37. 7 indexed citations
2.
Meier‐Hellmann, Andreas, et al.. (2003). Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients. Experimental and Toxicologic Pathology. 54(5-6). 493–498. 3 indexed citations
3.
Wedding, Ulrich, et al.. (2003). Pharmacokinetics of oxaliplatin during chronomodulated infusion in metastatic gastrointestinal cancer patients: A pilot investigation with preliminary results. Experimental and Toxicologic Pathology. 54(5-6). 475–479. 6 indexed citations
4.
Hippius, Marion, et al.. (2003). Adverse drug reaction monitoring in Jena. Experimental and Toxicologic Pathology. 54(5-6). 417–421. 1 indexed citations
5.
Farker, Katrin, et al.. (2003). Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC) – an investigation in a department of surgical medicine. Experimental and Toxicologic Pathology. 54(5-6). 387–391. 8 indexed citations
6.
Kath, R., et al.. (2002). Phase I clinical and pharmacokinetic study of combination chemotherapy with topotecan and ifosfamide in patients with progressive or relapsed solid tumors.. Journal of Cancer Research and Clinical Oncology. 128(6). 313–318. 5 indexed citations
7.
Farker, Katrin, Horst Schweer, Johannes Haerting, et al.. (2002). Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes. European Journal of Clinical Pharmacology. 58(2). 85–91. 10 indexed citations
8.
Herrmann, Andreas, et al.. (2002). Schwere Elektrolytstörung und ödeme unter Therapie mit Rosiglitazon. Medizinische Klinik. 97(9). 553–555. 4 indexed citations
9.
Schneeweiß, Sebastian, et al.. (2002). Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. European Journal of Clinical Pharmacology. 58(4). 285–291. 206 indexed citations
10.
Hippius, Marion, et al.. (2001). Adverse drug reaction monitoring – digitoxin overdosage in the elderly. International Journal of Clinical Pharmacology and Therapeutics. 39(8). 336–343. 8 indexed citations
11.
Hippius, Marion, et al.. (2001). Rhabdomyolyse als seltene Komplikation einer Theophyllinintoxikation. Medizinische Klinik. 96(1). 40–44. 2 indexed citations
12.
Meier‐Hellmann, Andreas, et al.. (1999). Serumspiegelorientierte Dosierung der einmal täglichen Aminoglykosidtherapie beim kritisch Kranken: Ergebnisse einer prospektiven Untersuchung. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 34(5). 288–296. 2 indexed citations
13.
Hippius, Marion, et al.. (1998). Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?. European Journal of Clinical Pharmacology. 54(9-10). 729–734. 24 indexed citations
14.
Wollina, Uwe, Dirk Prochnau, A Hoffmann, U.‐C. Hipler, & Reinhard Wetzker. (1998). Vasoactive intestinal peptide and epidermal growth factor: co-mitogens or inhibitors of keratinocyte proliferation in vitro?. International Journal of Molecular Medicine. 2(6). 725–30. 9 indexed citations
15.
Farker, Katrin, et al.. (1998). CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations.. PubMed. 36(9). 463–8. 14 indexed citations
16.
Farker, Katrin, Horst Schweer, Rüdiger Vollandt, et al.. (1997). Measurements of Urinary Prostaglandins in Young Ovulatory Women During the Menstrual Cycle and in Postmenopausal Women. Prostaglandins. 54(3). 655–664. 4 indexed citations
17.
Sinkiewicz, Włądysław, et al.. (1997). [Digoxin level as a limited drug toxicity indicator in the assessment of post-digitalis arrhythmia].. PubMed. 47(21-24). 808–12. 1 indexed citations
18.
Sigusch, Holger H., et al.. (1994). Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers. European Journal of Clinical Pharmacology. 46(2). 175–7. 48 indexed citations
19.
Truckenbrodt, J, et al.. (1991). Comparison of in vitro and in vivo biotransformation in patients with liver disease of differing severity. European Journal of Clinical Pharmacology. 41(5). 475–480. 11 indexed citations
20.
Hoffmann, A, et al.. (1990). [Effect of 3 months of thioacetamide treatment on liver biotransformation in vivo and in vitro (various times after discontinuation)].. PubMed. 50(4). 190–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shadi Baniasadi Breakdown of academic impact, for papers by Bruno HCh Stricker Breakdown of academic impact, for papers by Katrin Farker Breakdown of academic impact, for papers by Katja S. Just Breakdown of academic impact, for papers by William N. Kelly Breakdown of academic impact, for papers by Birgit Eiermann Breakdown of academic impact, for papers by Syed Rizwanuddin Ahmad Breakdown of academic impact, for papers by Just Ebbesen Breakdown of academic impact, for papers by Johanna Strandell Breakdown of academic impact, for papers by Esther H. Zhou
Rankless by CCL
2026